Literature DB >> 14517789

Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study.

George N Ioannou1, Noel S Weiss, Kris V Kowdley, Jason A Dominitz.   

Abstract

BACKGROUND AND AIMS: Our aim was to determine whether increased body mass index (BMI) in the general population is associated with cirrhosis-related death or hospitalization.
METHODS: Participants included 11,465 persons aged 25-74 years without evidence of cirrhosis at entry into the study, or during the first 5 years of follow-up, who subsequently were followed-up for a mean of 12.9 years. The BMI was used to categorize participants into normal-weight (BMI < 25 kg/m(2), N = 5752), overweight (BMI 25 to < 30 kg/m(2), N = 3774), and obese categories (BMI >/= 30 kg/m(2), N = 1939).
RESULTS: Cirrhosis resulted in death or hospitalization of 89 participants during 150,233 person-years of follow-up (0.59/1000 person-years). Cirrhosis-related deaths or hospitalizations were more common in obese persons (0.81/1000 person-years, adjusted hazard ratio 1.69, 95% confidence interval [CI] 1.0-3.0) and in overweight persons (0.71/1000 person-years, adjusted hazard ratio 1.16, 95% CI 0.7-1.9) compared with normal-weight persons (0.45/1000 person-years). Among persons who did not consume alcohol, there was a strong association between obesity (adjusted hazard ratio 4.1, 95% CI 1.4-11.4) or being overweight (adjusted hazard ratio 1.93, 95% CI 0.7-5.3) and cirrhosis-related death or hospitalization. In contrast, this association was weaker among persons who consumed up to 0.3 alcoholic drinks/day (adjusted hazard ratio 2.48, 95% CI 0.7-8.4 for obesity; adjusted hazard ratio 1.31, 95% CI 0.4-4.2 for overweight) and no association was identified among those who consumed more than 0.3 alcoholic drinks/day.
CONCLUSIONS: Obesity appears to be a risk factor for cirrhosis-related death or hospitalization among persons who consume little or no alcohol.

Entities:  

Mesh:

Year:  2003        PMID: 14517789     DOI: 10.1016/s0016-5085(03)01200-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

1.  Risk factors for alcoholic liver disease in China.

Authors:  Xiao-Lan Lu; Jin-Yan Luo; Ming Tao; Yan Gen; Ping Zhao; Hong-Li Zhao; Xiao-Dong Zhang; Nei Dong
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort.

Authors:  Kara B Johnson; Emily J Campbell; Heng Chi; Hui Zheng; Lindsay Y King; Ying Wu; Andrew Delemos; Abu Hurairah; Kathleen Corey; James M Richter; Raymond T Chung
Journal:  Dig Dis Sci       Date:  2013-08-30       Impact factor: 3.199

Review 3.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 4.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

Review 5.  Gastrointestinal morbidity in obesity.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Ann N Y Acad Sci       Date:  2014-03-06       Impact factor: 5.691

6.  Obesity increases the risks of diverticulitis and diverticular bleeding.

Authors:  Lisa L Strate; Yan L Liu; Walid H Aldoori; Sapna Syngal; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

7.  Obesity, overweight and liver disease in the Midspan prospective cohort studies.

Authors:  C L Hart; G D Batty; D S Morrison; R J Mitchell; G Davey Smith
Journal:  Int J Obes (Lond)       Date:  2010-02-09       Impact factor: 5.095

8.  Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies.

Authors:  Carole L Hart; David S Morrison; G David Batty; Richard J Mitchell; George Davey Smith
Journal:  BMJ       Date:  2010-03-11

9.  Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.

Authors:  Gábor Firneisz; Tímea Varga; Gabriella Lengyel; János Fehér; Dóra Ghyczy; Barna Wichmann; László Selmeci; Zsolt Tulassay; Károly Rácz; Anikó Somogyi
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

Review 10.  Nutrition and exercise in the management of liver cirrhosis.

Authors:  Nobuyuki Toshikuni; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.